Unit 2 Flashcards

1
Q

What are pharmacokinetics?

A

ADME principles:
- Drug chemistry
- Drug interactions
- Normal and abnormal body function

ADME =
Absorption, Distribution, Metabolism, Excretion

Absorption is preceded by disintegration/dissolution of drugs at the site of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the ADME principles?

A

ABSORPTION
How will it get in?

DISTRIBUTION
Where will it go?

METABOLISM
How is it broken down?

EXCRETION
How does it leave?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacokinetics is a balancing act. What are some of the questions we ask?

A

How much drug do we need to give?

What effect do we want?

What side-effects are we trying to avoid?

Questions dependent on innate drug chemistry:
- How are we giving the drug?
- How does the drug move around the body?
- How quickly is the drug eliminated?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does drug distribution depend on? How can we decide the distribution?

A

Drug distribution depends on drug chemistry and method of administration.

We can decide the drug distribution by altering drug formulation and administration to target specific tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is important about drug movement around the body?

A

Drug movement around the body is dynamic:

  1. Drug dose. Drug in solution at absorption site
  2. plasma-free drug ⇌ protein-bound drug
  3. Organs of bio-transformation form drug metabolites
  4. Site of action (target molecule) Bound ⇌ Free
  5. Tissue reservoirs Free ⇌ Bound
  6. Organs of excretion remove drug + metabolites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is water solubility?

A

Water is the universal solvent in biological systems and drugs need to be in aqueous solution:
- At the site of action to be able to achieve absorption
- To be distributed within the body
- At the site of action to be able to interact with a target molecule (e.g. receptor)
- To enable transport (in the circulation) to organs of excretion and metabolism

However, drugs must also be, to some extent, lipid soluble to cross cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe water vs lipid solubility:

A

Water is the universal solvent in biological systems.

Drugs need to be in aqueous solution:
- At the site of administration to achieve absorption
- To be distributed around the body
- At the site of action to be able to interact with the target molecule (e.g. a receptor)
- To enable passage (in the circulation) to organs of excretion and metabolism

HOWEVER,

Drugs with some lipid solubility:
- Cross cell membranes easily by passive diffusion
- Distribute into fatty tissue
- Will easily get to sites of actions within cells
- Will easily reabsorb from the kidney and therefore will need to be metabolised prior to excretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is the presence of drugs in plasma of significance?

A

The presence of drugs in plasma is of primary significance, except when the drug acts locally at the site of application or injection

BECAUSE

The (active) drug is only available for distribution to the site(s) of action, and for passage to the organs of excretion and metabolism, when it is in solution in plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do drugs move across cell membranes?

A

Most drugs are small molecules (molecular weight <1000). They pass across cell membranes by:

Passive diffusion along a concentration gradient (lipid soluble drugs)

Active or facilitated transport
- Pinocytosis
- Aqueous channels
- Carrier mediated transport (may be energy dependent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is pinocytosis?

A

Pinocytosis is a form of endocytosis, a cellular process by which cells internalize extracellular fluid and solutes into vesicles within the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do drugs move into/out of the circulation?

A

Drugs cross the vascular endothelium primarily through gaps between the cells - called FENESTRATIONS

The gaps are packed with a matrix of proteins that act to retain molecules of high molecular weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some factors affecting drug movement?

A

Properties of the drug:

Molecular weight: High molecular weight (met) compounds will remain at the site of administration

Lipid solubility: Lipid soluble drugs pass readily across cell membranes

Chemical nature: Drugs can be neutral, acidic or basic, polar or non-polar and the degree of ionisation therefore varies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is drug ionisation?

A

Influences the ability to cross cell membranes;

Weakly acidic or basic drugs (MOST):
- Partially ionised at physiological pH. The unionised fraction readily crosses cell membranes

Neutral drugs: 100% unionised;
- Readily cross-cell membranes

Strongly acidic or basic drugs: 100% ionised:
- Polar molecules that do not readily cross cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does pH affect absorption?

A

Most drugs are either weak acids or weak bases

Weak acids (HA):
HA ⇌ H+ + A-
unionised ⇌ ionised

Weak bases (B):
BH+ ⇌ B
ionised ⇌ unionised

UNIONISED: More readily absorbed

IONISED: Less readily absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Henderson-Hasselbalch equation?

A

pKa is the dissociation constant of a drug. When pH = pKa, A- = Ha, and B = BH+

pKa = pH + Log10 (protonated species / non-protonated species)

ACIDS: pKa = pH + log10 (HA/A-)

BASES: pKa = pH + log10 (BH+/B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

EXAMPLE: Effect of pH on drug on ionisation state in acid and alkali environments - Stomach + kidney and Pancreas

A

pKa = pH + log10 (HA/A-)

HA ⇌ A- + H+
Stomach: Low pH (~2)
Kidney: low pH (~2-4)
MOST DRUG IN HA, UNIONISED FORM

Pancreas: high pH (~7.5-8)
MOST DRUG IN A-, IONISED FORM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is diffusion/ion trapping of weak acids and bases?

A

This can occur when the pH differs on two sides of a membrane
- Weak acids are trapped in an ionised form in alkaline fluids
- Weak bases are trapped in an ionised form in acidic fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Summarise ionisation, solubility and transport in drugs:

A

UNIONISED (lipid soluble) molecules readily pass across lipid membranes

IONISED molecules do not easily pass across lipid membranes

The extent to which a drug is ionised, and therefore the rate and extent of its absorption (and distribution), is influenced by:
The pKa of the drug and local pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How well will aspirin, heparin and loperimide be absorbed?

Aspirin:
Mol. Wt: 180g/mol
Water soluble
(Weak acid)

Heparin:
Mol. Wt: 15kDa
Water soluble
(Strong acid)

Loperimide:
Mol wt: 477g/mol
Lipid soluble
(strong acid or base, depending on formulation)

A

ASPIRIN
Will cross well. Bioavailability 80-100%

HEPARIN
Big (large molecular weight) will absorb very slowly. Therefore not administered orally (is a blood thinner so will be intravenously administered). Bioavailability 0% from GIT

LOPERIMIDE
High lipid solubility but isn’t absorbed well. Bioavailability 0.3% p-glycoprotein substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

So what is drug absorption influenced by?

A

Route of administration
- Drugs can be given orally or parenterally

The route is determined primarily by the:
- Properties of the drug
- Therapeutic objective e.g. the need for;
Rapid onset of action
High plasma concentration
Long term administration
Restriction to a local site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Examples of uses for locally administered drugs:

Skin
Mucous membranes
Pinna
Intramammary
Oral
Epidural
Intra-articular
Rumen (retain devices)

A

Skin
- Flea treatment

Mucous membranes
- Eye drops

Pinna
- Antibiotics for ear infection

Intramammary
- Antibiotics for mastitis

Oral
- GIT problems, eg diarrhoea

Epidural
- Analgesics + local anaesthetics

Intra-articular
- Joint infection or inflammation

Rumen (retain devices)
- Sustained or pulsed release of anthelmintics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the physiological variables affecting drug absorption?

A

pH at site of absorption

Area of absorbing surface (e.g. following oral administration, most drug absorption occurs in the intestines. A reduction in the surface area for absorption will decrease the amount of drug absorbed)

Local blood flow (e.g. decreased perfusion will reduce the rate of diffusion of a drug from the site of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is bioavailability as a measure of absorption?

A

Bioavailability is:

The fraction of the administered dose that reaches the systemic circulation in an active form

It is expressed as a percentage of the total administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is bioavailability?

A

Bioavailability = area under the curve of oral dose / area under the curve of IV dose

Takes NO account of the rate of drug absorption therefore:
- Two drugs may have the same bioavailability but the peak plasma concentration will be higher if one is absorbed more rapidly
- A difference in the peak concentration achieved may affect the therapeutic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What can drugs distribute into?

A

Once absorbed from the site of administration drugs can distribute into:

Plasma (if a drug has been given intravenously it will, of course, already be present in plasma)

Extracellular fluid (ECF)
- Interstitial fluid
- Transcellular fluid

Intracellular fluid (ICF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is drug distribution in body compartments?

A

Volume of distribution, Vd, is a measure of the volume of fluid required to contain the total amount of drug at its plasma concentration

If the body was a compartment, the drug would be the same thoroughout.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is greater Vd reflected by?

A

Greater Vd is reflected by lower drug concentration.

a) After injection the drug could just stay in the circulation

b) The drug could distribute into extracellular fluid, reducing the plasma concentration

c) The drug could distribute into total body water; if it does the concentration of drug in the plasma will be lower than if it had just distributed into the circulation and ECF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do we calculate Vd?

A

Vd = Q Dose (total amount of drug in the body; mg/kg) / Cp Plasma concentration (usually µg or ng/ml)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How can we interpret the volume of distribution?

A

Vd VERY LOW (0.05 to 0.1 L/kg): Drug confined to the plasma compartment (large molecules)

Vd LOW (0.2 L/kg): Drug confined to the plasma and interstitial space (highly polar molecules which penetrate membranes poorly)

Vd INTERMEDIATE (0.6 L/kg): Drug enters total body water (crosses membranes)

Vd VERY HIGH (>1 L/kg): Drug concentrates in fat or binds to a site within a tissue or cell

TOTAL BODY WATER = APPROX 0.6 L/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Why is it important to know the Volume of distribution of a drug?

A
  1. It enables you to predict whether the drug selected for administration is likely to reach the target site at effective concentrations
  2. The Vd can be used to determine the loading dose necessary to achieve a target plasma concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is Vd?

A

The ability of a drug to leave the circulation and enter interstitial fluid (and then to cross cell membranes) can be influenced by:
- Size
- Plasma protein binding
- Endothelial cell barrier function
- Ion trapping
- Lipid solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What do we know about plasma protein binding?

A

Once a drug has entered the vascular compartment, it may circulate bound to plasma albumin and globulin

The plasma protein bound and free drug in the circulation are in equilibrium

Normally only the free drug crosses the endothelial cell barrier

Drug + Plasma protein
t = 0 total concentration

t = n total concentration and unbound concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are some variations in plasma protein?

A

Drug binding to plasma protein occurs to a variable extent (from 0% to 99%)

There are species difference in the extent to which a drug is plasma protein bound

Displacement can occur if two extensively plasma protein-bound drugs are given together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the consequences of drug-plasma protein binding?

A

Pharmacodynamics:
The protein-bound fraction is pharmacologically inactive

Pharmacokinetics:
Only the free portion of a protein-bound drug will readily leave the circulation/be ultra-filtered in the kidney

Toxicity:
In a few individuals, the drug-protein complex may be recognised as ‘foreign’ i.e. behaves as an antigen, causing a hypersensitivity reaction on second exposure

Interactions:
Competition between drugs or endogenous compounds for protein binding can occur which may lead to unwanted effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Summarise drug distribution:

A

Drug can distribute in plasma, interstitial fluid or trancellular fluid (ECF compartments) and intracellular fluid (ICF)

Volume of distribution can be calculated from plasma concentration, and used to predict this distribution

Drug chemistry, particularly plasma protein binding, is the major determinant of drug distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is drug metabolism?

A

Most drugs require metabolism prior to elimination from the body

This converts drugs into more water-soluble compounds and aids their elimination

Some drug metabolites are biologically active

Some drugs are administered as inactive, pro-drugs and must be metabolised to an active form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the sites of metabolism?

A

The LIVER is the main site of drug metabolism

Some drugs may be metabolised in other tissues e.g. PLASMA, wall of the GASTROINTESTINAL TRACT, LUNG and KIDNEY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the process of metabolism?

A

Drugs metabolised in the liver must be able to cross the liver cell membrane to reach the microsomal enzymes

The main enzymes involved in drug metabolism in the liver are the mitochondrial mixed function oxidase enzymes, otherwise known as cytochrome P-450 or CYP enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the phases in metabolism?

A

Hepatic metabolism is normally biphasic

PHASE 1:
Convert lipophilic molecules into more polar molecules

PHASE 2:
Add a conjugating group to the molecule to increase polarity, decrease lipophilicity, and therefore aid drug excretion

STEP BY STEP
1. Drug
2. Phase 1: oxidation, reduction, hydrolysis
3. Metabolite
4. Phase 2: Conjugation. Addition of e.g. glucuronic acid, glycine, sulphate, acetyl
5. Conjugate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is first pass metabolism?

A

Some drugs are extensively metabolised in the wall of the gastrointestinal tract or in the portal blood or in the liver before they reach the systemic circulation

First pass metabolism affects the absorption of orally administered drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is enterohepatic (re)cycling (some drugs)?

A

Liver cells transfer drugs or drug conjugates to bile

They are delivered to the intestines where:
- Conjugates are hydrolysed
- The parent drug
- Can be reabsorbed

42
Q

Summarise metabolism:

A

The liver is the main site of drug metabolism

Extrahepatic metabolism can occur in the plasma, wall of the gastrointestinal tract, lung and kidney

Following conjugation, some drugs can be returned to the plasma as part of enterohepatic recycling.

43
Q

What is drug excretion?

A

Occurs primarily in the urine and bile

Water soluble molecules tend to be excreted most efficiently as they are not reabsorbed (some are secreted into the renal tubule)

44
Q

What are the steps of renal excretion?

A
  1. No filtration (proteins >70,000kD)
  2. Partial filtration (drugs bound to plasma proteins; free drug is filtered)
  3. Filtered then completely reabsorbed (e.g. glucose)
  4. Filtered then completely reabsorbed from the tubules, partially excreted (most drugs)
  5. Filtered then no reabsorption from the tubules (ionised, water soluble drugs; many drug metabolites)
  6. Filtered then actively secreted into the tubule (some drugs and drug metabolites)
45
Q

What is secretion in renal excretion?

A

Filtered then actively secreted (some drugs)

Secretion is an active, energy-dependent process involving transporter proteins in the cell membrane. The process is selective and saturable

Note that there are transporter proteins for drugs in many other tissues including the intestinal epithelium

Transporter proteins play a physiological role in moving endogenous substances into and out of cells (influx and efflux pumps). They are also important in regulating drug absorption and distribution.

46
Q

What is the effect of pH on rate of excretion?

A

The rate of excretion in the urine of drugs that are weak acids or weak bases depends on urine pH because this influences the proportion of unionised and ionised drug.

In animals producing acidic urine (carnivores, concentrate fed herbivores) weak bases will be eliminated most efficiently

In animals producing alkaline urine (herbivores on forage), weak acids will be eliminated most efficiently.

47
Q

What is renal excretion vs hepatic metabolism?

A

RENAL EXCRETION:
- Main elimination process for polar (non-lipophilic) drugs
- Most renal mechanisms (ultrafiltration, reabsorption) are passive
- Species differences in drug clearance and half-life are usually minor.

HEPATIC METABOLISM:
- Main elimination process for lipophilic drugs
- Enzyme driven, active processes
- Species differences in drug clearance and half-life are usually marked

48
Q

What are the pharmacokinetic parameters?

A

A wide range of pharmacokinetic parameters can be calculated from plasma (or urine) concentration-time data

These provide useful QUANTITATIVE data on ADME

Quantitative data are essential for:
- A full understanding of drug absorption into, fate within, and elimination from the body
- Design of dosage schedules for safe and effective clinical use

49
Q

What are some examples of useful pharmacokinetic parameters?

A
  • Cmax
  • Tmax
  • AUC
  • Bioavailability (F) and Bioequivalence
  • Vd
  • Cl
  • T1/2
  • First and zero-order processes
50
Q

What happens to the plasma concentration of the drug over time?

A

Plasma concentration rises, absorption > elimination

Plasma concentration peaks and stabilises, absorption = elimination

Plasma concentration falls, elimination > absorption

51
Q

What is therapeutic index (TI)?

A

A drug with a narrow therapeutic index has a low safety margin, producing unwanted effects at doses close to those that produce the desired effect

52
Q

What is Cmax?

A

Cmax, or maximum plasma concentration, refers to the peak concentration of a drug in the bloodstream after administration
(shown as the peak in a plasma conc / time graph)

53
Q

What is Tmax?

A

Tmax, or time to maximum plasma concentration, refers to the time it takes for a drug to reach its maximum concentration, or Cmax, in the bloodstream after administration.
(shown as the x intercept at the peak on a plasma conc / time graph)

54
Q

What does the area under the curve in a plasma concentration / time graph show?

A

Provides an estimate of the amount of drug in the body over a period of time (e.g. 24hrs or the inter-dosing interval) and can be used to determine BIOAVAILABILITY

55
Q

What is bioavailability (formula)?

A

The fraction of the administered dose that reaches the systemic circulation in an active form

It is expressed as a percentage of the total administered

F = Area under curve (non vascular) / Area under curve (IV) x 100%

56
Q

What is bioequivalence?

A

Two medicinal products containing the same drug but which have different formulations are bioequivalent only if the rate and extent of drug absorption is the same

In practice this is when there are no significant differences between the AUC, Cmax and Tmax.

57
Q

What is Clearance, Cl?

A

Units: ml/h (or mins) / kg

The volume of blood {plasma} effectively cleared of drug by an eliminating organ per unit time

E.g. renal clearance, which is determined by measuring drug concentrations in urine and plasma and the rate of urine flow

% urinary excretion = the proportion of a drug dose that is excreted unchanged in the urine

Note most drugs are metabolised to some extent. For the few that are not, the rate of renal clearance will be the main factor determining the duration of action

58
Q

What is the (elimination) half life of a drug, T1/2?

A

The time taken for the concentration of drug in the plasma to fall by 50%

T1/2 is calculated from a log plasma concentration vs time curve

59
Q

What are first-order pharmacokinetics?

A

First-order pharmacokinetics refers to a type of pharmacokinetic process in which the rate of drug elimination is proportional to the concentration of the drug in the body. This means that a fixed proportion is removed per unit time.

Most drugs are eliminated by first-order kinetics.

There is an exponential decrease in drug concentration over time so a plot of plasma concentration against time is a curve.

Therefore Half-life (T1/2) is independent of dose

Elimination pathways are not saturated.

60
Q

What are zero order (saturation) pharmacokinetics?

A

Relatively rare. Examples; salicylate (cat); phenytoin (man)

There is a linear decrease in plasma drug concentration over time, i.e. the decline is not proportional to the drug concentration. Therefore a fixed amount of drug is removed per unit time

T1/2 increases as the administered dose increases

This is because of saturation of elimination pathways (usually hepatic enzymes or active secretion into the proximal convoluted tubule in the kidney).

Therefore an increase in plasma drug concentration readily occurs with dose.

61
Q

How do we achieve steady-state plasma concentrations?

A

Cumulation to “steady state” with repeat drug dosing

Administer series of doses at half-life intervals

Peak and trough concentrations rise to attain a plateau after approx. 5 elimination half-lives

62
Q

What are side effects?

A

Use of almost all drug products is associated with side-effects

A side-effect is an unwanted action caused by a drug used at a therapeutic dose

Side-effects vary in severity and may be acute or chronic

Adverse drug reaction is a term used to describe any unwanted event associated with use of a drug at therapeutic doses. This can also be referred to as drug toxicity.

Side effect strengths:

Limited significance –> debiliating –> disabling –> fatal.

63
Q

How do we optimise dosing schedules?

A

The effective and safe clinical use of drugs depends on optimising dose schedules

i.e.
- The amount of drug given
- and the dosing interval
- and the duration of treatment
- and the route of drug administration

64
Q

What are three possible approaches to finding an optimal drug dose?

A
  1. Administer a series of doses (e.g. placebo, 1x, 2x, 4x, 8x, 16x) to groups of animals in cross-over or parallel design studies (DOSE TITRATION)
  2. Pharmacokinetic (PK) and Pharmacodynamic (PD) in target species are established in separate studies and the results are then combined (PK-PD integration)
  3. Establish PK and PD in a single study and model data in silicon (PK-PD MODELLING)
65
Q

What are factors affecting drug pharmacokinetics?

A

Variation in Pharmacokinetics may affect:
- Therapeutic efficacy (increased or decreased)
- Toxicity (increased or decreased)

Therefore it may require:
- Adjustment of dosing interval or dose

66
Q

What are drug/drug product factors potentially altering drug pharmacokinetics?

A
  • Lipid solubility
  • Stability
  • Dose (first and zero order kinetics)
  • Acidic or basic nature and renal excretion
  • Chirality
  • Plasma protein binding
  • Effects on hepatic enzymes
  • Product formulation
67
Q

What does acidic/basic nature do to affect pharmacokinetics?

A

The rate of excretion in the urine of drugs that are weak acids and bases depends on urine pH

Animals producing acidic urine will eliminate basic drugs most efficiently

Animals producing alkaline urine will eliminate acidic drugs most efficiently

Administration of an alkalinising or acidifying agent will alter urine pH. Depending on the % urinary excretion, this approach can be used to speed up the rate of drug elimination from the body

% urinary excretion is the percentage of drug excreted unchanged in the urine.

68
Q

What happens in competition for plasma protein binding?

A

Drugs can compete for binding sites with endogenous compounds. If the concentration of an endogenous compound changes, it may affect the concentration of free drug in the plasma

And

If the increase in plasma concentration affects the rate of drug clearance, it will prolong the presence of active drug in the body.

69
Q

What is chirality?

A

Chiral drugs exist as enantiomers (a pair of compounds that are mirror images of one another)

The pharmacokinetic properties of one enantiomer may differ from the other (they may also have different pharmacodynamic properties)

One enantiomer may be converted to the other in the body (chiral inversion)

70
Q

What are some examples of drugs and their isomer potency?

A

Salbutamol = S+ isomer inactive

Ketamine = R- form causes hallucination and agitation

DOPA = d-DOPA toxic

ß-blockers = d- and l-enantiomers have different PK, particularly metabolism

Verapamil = S- form 10-20 times greater potency than R+ form

71
Q

What are metabolising enzymes and drug interactions?

A

Liver enzyme induction can be caused by repeated administration of some drugs
- Examples: phenobarbitone and phenytoin (anti-epileptic drugs)

Some drugs cause inhibition of liver enzymes
- Examples: chloramphenicol (antibacterial drug) and cimetidine (reduces gastric acid secretion by inhibiting the actions of histamine at H2 receptors located on parietal cells)

72
Q

What are the consequences of liver enzyme induction or inhibition?

A

Plasma drug concentrations will be decreased (enzyme induction) or increased (enzyme inhibition)

Therapeutic efficacy may be lost (enzyme induction) or toxic effects may develop (enzyme inhibition).

Dosing intervals may need to be adjusted

73
Q

What are some examples of formulation?

A

The formulation of a solution for intramuscular injection can be altered so that the aqueous solubility is reduced; this prolongs the duration of action of the drug (e.g. long-acting (depot) products that are given by intramuscular injection)

Drugs that are broken down in acidic conditions can be protected by an enteric coating

The particle size or structure of tablets can be altered so there is slow or sustained release.

74
Q

What can be the effects of food on Cmax and Tmax?

A

Administering with food may cause the Cmax to increase, decrease or stay the same depending on the drug

75
Q

What factors influence absorption from the GIT?

A

Gastric or intestinal motility (e.g. increased motility decreases the time available for drug absorption)

Splanchnic blood flow (e.g. reduced blood flow due to disease decreases drug absorption)

Stability of drug (e.g. some drugs are unstable in gastric acid or are broken down by enzymes)

Damage to, or loss of, the epithelial barrier (which can be caused by drugs or disease) reduces drug absorption

76
Q

What is chronopharmacokinetics?

A

Dosing at the same time each day to avoid variation in factors such as metabolic rate or blood flow to the gastrointestinal tract which may affect drug pharmacokinetics

77
Q

What are disease effects when relating to pharmacokinetics?

A

Pharmacokinetics may be altered by hepatic or renal disease and drug doses may need to be adjusted

Effects of hepatic disease are difficult to predict but, in general, the dosing interval will need to be increased

The higher the proportion of a drug dose that is excreted unchanged by the kidneys, the greater the effect of renal disease.

Drug absorption and distribution may be affected by cardiac disease. Regional blood flow can vary in cardiovascular disease

Infiltrative gut disease will reduce drug absorption

Dehydration or acidosis can affect drug distribution e.g. poor absorption of drugs from a subcutaneous injection site where an individual is dehydrated.

78
Q

How may physiological state affect pharmacokinetics?

A

E.g. in a stressed individual, the metabolic rate may increase speeding up active processes BUT drug distribution may be affected if the blood supply to the periphery is altered

79
Q

EXAMPLE: What is the effect of anaesthesia on Carprofen pharmacokinetics?

A

Carprofen - given intra-operatively (as part of the pre-medication) or post-operatively at an oral dose of 4.0mg/kg to dogs undergoing surgery

Pre-op Cmax = 11.0 µg/ml
Pre-op AUC = 115 g/ml.h
Post-op Cmax = 20.6 µg/ml
Post-op AUC = 175 µg/ml.h

80
Q

What do we know about pharmacokinetics in neonates (relative to adults)?

A

Reduced rate of renal excretion

Reduced rate of hepatic metabolism

Lower amount of plasma protein binding

Greater absorption from the GIT (bioavailability)

Possible increased permeability of the blood-brain barrier

Increased volume of distribution

81
Q

What are the renal and hepatic mechanisms of elimination in elderly individuals?

A

Some general decline in the efficiency of elimination mechanisms in the liver and kidney

Changes are less specific than in neonates therefore it is not possible to generalise

There are drug dependent differences and differences between individuals

Adjustment to dosage schedules may be required

More research is needed in animals

82
Q

Does gender affect pharmacokinetics?

A

Many examples of differences observed in man

Likely also to exist in animals. For example, gender differences in CYP isoenzymes have been reported in rats, affecting the rate of drug metabolism

83
Q

What are some conclusions we can make about the properties of a drug and its pharmacokinetics?

A

Knowing the properties of a drug and its pharmacokinetics in the normal animal/human and how these may affect drug pharmacokinetics enables the adjustment of the dose or dosing interval - if necessary.

84
Q

What may variation in pharmacokinetics affect?

A

Therapeutic efficacy (increased or decreased)

Toxicity
(increased or decreased)

Therefore it may require:
Adjustment of dosing interval or dose

85
Q

What are some animal/human factors potentially altering drug pharmacokinetics?

A
  • Administration route
  • Food
  • Time of day
  • Disease
  • Physiological state
  • Gender
  • Species
  • Breed
86
Q

What may some factors leading to species differences in drug disposition affect?

A
  • Absorption
  • Protein binding
  • Elimination (metabolism and excretion)
  • There can be marked species differences in the half life of a drug, and therefore in the inter-dosing interval required
87
Q

What differences in absorption may we observe?

A

There can be considerable variation in the bioavailability of drugs given orally due to differences in the anatomy of the gastrointestinal tract

NB: other species dependent factors may contribute to observed differences in AUCs e.g. rapid metabolism

Differences between monogastric and ruminant species can be particularly marked

The rate and extent of percutaneous absorption can also vary between species due to differences in the structure of the skin

88
Q

How can we explain species variability and differences in binding?

A

There is species variability in the extent of drug binding to plasma proteins.

Differences in binding cannot be explained solely by variation in protein concentration and may be due to differences in protein composition and conformation

89
Q

How might metabolism vary between species?

A

Differences between species are very common and may be qualitative or quantitative

Qualitative:
When a reaction is deficient in a particular species

Quantitative:
When there is a difference in the amount of enzyme present. This is very common and leads to major pharmacokinetic differences between species, notably in clearance and elimination half-life

90
Q

What may species differences in biotransformation result in?

A

A drug being used safely provided the dosing interval is increased

E.g. in cats, aspirin is very slowly conjugated with glucuronic acid and the T1/2 is about 37.5hrs versus 8.5hrs in the dog

A drug that can be used in one species not being safe to use in another

E.g. in cats, paracetamol is metabolised by an alternative pathway to glucuronidation leading to the production of a toxic metabolite.

91
Q

Some drugs are excreted by the liver into bile, what is the relative importance of this?

A

The relative importance of this route varies between species

E.g. % of an I.V dose of carprofen eliminated by biliary secretion

Dogs 70%
Humans 30-35%
(little recovered in faeces due to enterohepatic recycling)

92
Q

What are the differences between species in hepatic elimination?

A

Species differences in elimination half-life are the rule rather than the exception

Differences can be profound and they are not easily predicted from the knowledge of the kinetics of related drugs or related animal species

Do not extrapolate between species

Half-life values are often longer in man than in other animal species

93
Q

What are some other species differences in metabolising enzymes?

A

There are also species differences in metabolising enzyme found in other sites in the body

E.g. plasma pseudocholinesterase (similar in structure to acetylcholinesterase)

Low activity in pigs and ruminants

Renal excretion in urine is less species dependent that drug metabolism as much of the process is passive

94
Q

What are species differences and rate of drug excretion?

A

The rate of excretion of weak acids and bases in the urine depends on urine pH

Animals producing acidic urine (carnivores, concentrate fed herbivores) will eliminate basic drugs most effectively

Animals producing alkaline urine (herbivores on forage) will eliminate acidic drugs most efficiently

95
Q

What are Chiral compounds?

A

Exist as enantiomers which, structurally, are mirror images of one another

Products containing chiral compounds are usually comprised of a mixture of enantiomers (e.g. salbutamol (Ventolin) is a 50:50 mixture of the R- and S+ enantiomers)

Typically, only one enantiomer is biologically active (but the other may have unwanted effects) (e.g. S-ibuprofen is 100-fold more potent as COX1 inhibitor rather than R-ibuprofen)

Two enantiomers may be eliminated from the body at different rates

Chiral inversion in which one enantiomer is converted to the other (e.g. inactive R-ibuprofen can undergo chiral inversion by hepatic enzymes) may occur in one species but not in another

96
Q

What may breed cause differences in?

A

Drug half life

Passage across the blood-brain (B-B) barrier

Metabolism

CYP isoenzyme activity

97
Q

How does breed cause variation in passage across the blood-brain (B-B) barrier?

A

Passage across the blood-brain (B-B) barrier:

  • E.g. Avermectins (e.g. ivermectin) are more likely to accumulate in the CNS of collie dogs and related breeds causing toxicity
  • This is caused by a defect in the ABCB1 (also known as P-glycoprotein or MDR1) efflux transporter located on the blood-brain barrier due to a gene mutation in susceptible individuals
98
Q

How does breed cause variation in metabolism?

A

Breed difference in metabolism (of the COX-2 inhibitor, celecoxib)

Two sub-populations, distinguished by their capacity to eliminate celecoxib (Extensive Metabolisers (EM) 45% Poor Metabolisers (PM) 53.5% and uncharacterised 1.65%) were identified in a population of 242 beagle dogs

Hepatic microsomes from EM dogs metabolised celecoxib more rapidly than those PM dogs

99
Q

How does breed cause variation in CYP isoenzyme activity?

A

E.g. lower activity of CYP2B11 in some dog breeds. Greyhounds recover slowly from the general anaesthetic propofol. This can be explained by a reduced rate of hydroxylation and therefore increased drug clearance time

Mutations in CYP isoenzymes have also been noted in other domestic animal species

100
Q

What are sources of variability in drug responses?

A

Species and breed differences in:
- Pharmacokinetics
- Pharmacodynamics

When treating groups of animals:
- There is likely to be variability in the dose received by individual animals when drugs are given in feed or in the water
- The sickest and weakest animals may receive an inadequate dose

When treating individual animals:
- Owner compliance